Central cardiovascular effects of morphinomimetic peptides in dogs
Authors:
- Michel LaubieMLMichel Laubie
- Henri SchmittHSHenri Schmitt
- Michel VincentMVMichel Vincent
- Georges RemondGRGeorges Remond
- 1 November 1977
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 46 (1) , 67-71
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In vitro pharmacology of the opioid peptides, enkephalins and endorphinsEuropean Journal of Pharmacology, 1977
- An Analog of Enkephalin Having Prolonged Opiate-Like Effects in VivoScience, 1977
- Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medullaBrain Research, 1977
- Central sites and mechanisms of the hypotensive and bradycardic effects of the narcotic analgesic agent fentanylNaunyn-Schmiedeberg's Archives of Pharmacology, 1977
- Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental IllnessScience, 1976
- [D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide AnalgesicScience, 1976
- Localization of the central sympatho-inhibitory effect of a narcotic analgesic agent, fentanyl, in catsEuropean Journal of Pharmacology, 1975
- Centrally mediated bradycardia and hypotension induced by narcotic analgesics: Dextromoramide and fentanylEuropean Journal of Pharmacology, 1974
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968